Kalvista Pharmaceuticals, Inc. (KALV)

Last Three Months

18-Jun-21 -- 17-Sep-21

Time Period:
  • Three Months
  •  | 
  • Year

($467.19K) Net Amount
Buy:0--
Sell:($467.19K)$20.52 - $24.15

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Sell
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
1
(3)
2
(2)
0
(1)
14
0
0
+1
0
+2
0
+3

Two Year Chart

18-Sep-19 -- 17-Sep-21

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
04-Aug-21 7:55 PM
View: 
02-Aug-21
Market Sale (Planned)
($102.58K)
Yea Christopher
Chief Development Officer
Insider Trading Sentiment for Yea Christopher at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV(12%)
42.97K to 37.97K
0
($102.58K)
(12%)
--$20.52 Show TxnsShow Insider Trades
04-Aug-21 7:55 PM
View: 
02-Aug-21
Market Sale (Planned)
($123.13K)
Feener Edward P.
Chief Scientific Officer
Insider Trading Sentiment for Feener Edward P. at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV(42%)
14.23K to 8.23K
0
($123.13K)
(42%)
--$20.52 Show TxnsShow Insider Trades
02-Jul-21 10:00 PM
View: 
01-Jul-21
Market Sale (Planned)
($241.48K)
Insider Trading Sentiment for Crockett Thomas Andrew at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV(7%)
144.67K to 134.67K
0
($241.48K)
(7%)
--$24.15 Show TxnsShow Insider Trades